Clinical Trial Update: Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing nitazoxanide combined with peginterferon alfa-2a and ribavirin in treatment-naive chronic hepatitis C patients, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Nitazoxanide (nitazoxanide)
• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Romark Laboratories L.C. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-01-06